Compare Medpace Holdings Inc (MEDP) vs Personalis Inc. Common Stock (PSNL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Personalis Inc. Common Stock — how do they compare? Medpace Holdings Inc trades at $616.98 (market cap $17.21B), while Personalis Inc. Common Stock trades at $15.95 (market cap $1.70B). The key difference: Medpace Holdings Inc is far larger — about 10.1× Personalis Inc. Common Stock's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Personalis Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Personalis Inc. Common Stock for 0 Days on average.
| MEDP | PSNL | |
|---|---|---|
Market Cap | $17.21B | $1.70B |
Volume | 311,245 | 3,262,398 |
Sector | Health | Health |
52-Week High | $630.19 | $18.38 |
52-Week Low | $393.42 | $5.04 |
Typical Hold Time | 14 Days | 0 Days |
Enterprise Value | $16.83B | $1.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $609.89, down 1.64% today, with a bullish technical signal and strong support near $606. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue grew to $2.53B in 2025, with a net income margin of 17.67%. Recent news highlights CEO stock sales and institutional position adjustments.
Outlook remains positive with a consensus price target of $620.44, offering modest upside. Key risks include high valuation multiples and insider selling. Earnings growth and sector demand are primary catalysts, but investor caution is warranted given elevated P/E and P/B ratios.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Personalis Inc. Common Stock
Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →
